111 related articles for article (PubMed ID: 12034523)
1. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
2. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
Tefre T; Børresen AL; Aamdal S; Brøgger A
Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
[TBL] [Abstract][Full Text] [Related]
3. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
[TBL] [Abstract][Full Text] [Related]
4. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
6. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
7. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients.
Ge H; Lam WK; Lee J; Wong MP; Yew WW; Lung ML
Lung Cancer; 1996 Nov; 15(3):355-66. PubMed ID: 8959680
[TBL] [Abstract][Full Text] [Related]
8. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
9. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of the S-allele of the L-myc oncogene in breast cancer.
Isbir T; Yaylim I; Arîkan S; Küçücük S; Camlíca H
Mol Med; 2002 Sep; 8(9):521-4. PubMed ID: 12456990
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.
Zborovskaya I; Gasparian A; Kitaeva M; Polotzky B; Tupitzin N; Machaladze Z; Gerasimov S; Shtutman M; Jakubovskaya M; Davidov M; Tatosyan A
Clin Exp Metastasis; 1996 Nov; 14(6):490-500. PubMed ID: 8970579
[TBL] [Abstract][Full Text] [Related]
12. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.
Kawashima K; Nomura S; Hirai H; Fukushi S; Karube T; Takeuchi K; Naruke T; Nishimura S
Int J Cancer; 1992 Feb; 50(4):557-61. PubMed ID: 1347036
[TBL] [Abstract][Full Text] [Related]
13. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
14. Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs.
Kawashima K; Shikama H; Imoto K; Izawa M; Naruke T; Okabayashi K; Nishimura S
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2353-6. PubMed ID: 2895475
[TBL] [Abstract][Full Text] [Related]
15. MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Smith PJ
Br J Cancer; 1996 Dec; 74(12):1975-8. PubMed ID: 8980399
[TBL] [Abstract][Full Text] [Related]
16. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
[TBL] [Abstract][Full Text] [Related]
17. Different susceptibility of each L-myc genotype to esophageal cancer risk factors.
Kumimoto H; Hamajima N; Nishizawa K; Nishimoto Y; Matsuo K; Harada H; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2001 Jul; 92(7):735-9. PubMed ID: 11473723
[TBL] [Abstract][Full Text] [Related]
18. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
19. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
20. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]